Abstract
Mildronate is a cardioprotective agent whose mechanism of action is based on decrease in L-carnitine concentration in heart tissue and concomitant decrease in fatty acid metabolism. The present study was...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have